3 min read · Aug 26th · An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix. Lifesaving COVID-19 vaccines…
An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix.
Following exciting lab results, the developers designed sotrovimab based on the structure of S309, and evaluated it in clinical trials.
Using biochemical and structural analysis, deep mutational scanning, and binding experiments, they identified one antibody with unparalleled universal potency.
4 min read · Sep 23rd · This has become a common refrain among the cautious—and it’s wrong.
So let me make one thing clear: Vaccinated people are not as likely to spread the coronavirus as the unvaccinated.
Despite concern about waning immunity, vaccines provide the best protection against infection. And if someone isn’t infected, they can’t spread the coronavirus.
Everyone knows that the vaccines help protect each individual who gets their shots. But when more people get vaccinated, this helps keep everyone else (including children and others ineligible for vaccination) safe as well.
6 min read · Sep 2nd · Mocking the unvaccinated dead does not save lives.
The tsk-tsk obituary reflects that exact mentality, which is useful only if you hope to persuade someone who would’ve already been persuaded in the first place.
after the 22 percent who aren’t sure that the vaccines are actually protective, are another 17 percent who don’t see COVID-19 as a major threat—a fairly small minority, all things considered.
What strikes me about the responses of the unvaccinated—as opposed to the tempting caricature presented by their worst representatives in pulpits and politics—is that there does seem to be significant willingness to consider vaccination
4 min read · Jul 26th · Some patient's who've had COVID-19 develop symptoms resembling early Alzheimer's. Researchers are trying to figure out whether these people are more likely to develop the disease itself.